MedTrace Logo

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

NCT04281732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-02-24

No results posted yet for this study

Summary

Purpose:

To validate a newly developed battery of performance-based tests of visual function to be presented using virtual reality. The tests are intended as potential outcome measures for clinical trials of treatments of eye disease: they measure visual performance in patients with low vision on visual tasks that a relevant for daily life.

Conditions

  • Low Vision
  • Retinitis Pigmentosa
  • Stargardt Disease 1
  • Stargardt Disease 3
  • Stargardt Disease 4
  • Albinism

Interventions

DEVICE

Virtual Reality Headset based tests

Visual task tests based on Oculus Rift

Sponsors & Collaborators

  • University of Sussex

    collaborator OTHER

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Ruth E Hogg, PhD · Queen's University, Belfast

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-09-30
Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281732 on ClinicalTrials.gov